StockData
Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc (TNDM) stock

TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3030% below fair value
$17.06−1.42 (-7.68%)

Close on Nov 17, 2026Market cap $1.19BP/E –Yield –

Tandem Diabetes Care cash

Cash and short-term investments held at the end of each period.

Tandem Diabetes Care's cash was $456.00M at Jun 30, 2026. For fiscal 2025 it was $292.67M, down 33.2% from the year before. Over ten years it grew 15.2% a year on average. The highest annual figure on record is $623.81M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$292.67M-33.2%
FY2024Dec 31, 2024$438.33M-6.3%
FY2023Dec 31, 2023$467.91M-24.2%
FY2022Dec 31, 2022$616.90M-1.1%
FY2021Dec 31, 2021$623.81M+28.6%
FY2020Dec 31, 2020$484.94M+174.8%
FY2019Dec 31, 2019$176.50M+36.8%
FY2018Dec 31, 2018$129.00M+433.5%
FY2017Dec 31, 2017$24.18M-54.8%
FY2016Dec 31, 2016$53.50M-24.8%
FY2015Dec 31, 2015$71.11M+5.7%
FY2014Dec 31, 2014$67.28M-48.0%
FY2013Dec 31, 2013$129.48M+654.4%
FY2012Dec 31, 2012$17.16M+98.3%
FY2011Dec 31, 2011$8.66M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$456.00M+44.6%
Q1 FY2026Mar 31, 2026$570.26M+54.7%
Q4 FY2025Dec 31, 2025$292.67M-33.2%
Q3 FY2025Sep 30, 2025$319.11M-32.6%
Q2 FY2025Jun 30, 2025$315.36M-30.3%
Q1 FY2025Mar 31, 2025$368.63M-21.2%
Q4 FY2024Dec 31, 2024$438.33M-6.3%
Q3 FY2024Sep 30, 2024$473.31M-5.0%
Q2 FY2024Jun 30, 2024$452.42M-10.8%
Q1 FY2024Mar 31, 2024$467.81M-10.0%
Q4 FY2023Dec 31, 2023$467.91M-24.2%
Q3 FY2023Sep 30, 2023$498.16M-18.2%
Q2 FY2023Jun 30, 2023$507.25M-20.2%
Q1 FY2023Mar 31, 2023$519.59M-18.2%
Q4 FY2022Dec 31, 2022$616.90M-1.1%
Q3 FY2022Sep 30, 2022$608.73M+2.3%
Q2 FY2022Jun 30, 2022$635.33M+16.5%
Q1 FY2022Mar 31, 2022$635.39M+23.8%
Q4 FY2021Dec 31, 2021$623.81M+28.6%
Q3 FY2021Sep 30, 2021$594.99M+28.1%
Q2 FY2021Jun 30, 2021$545.30M+27.9%
Q1 FY2021Mar 31, 2021$513.44M+220.5%
Q4 FY2020Dec 31, 2020$484.94M+174.8%
Q3 FY2020Sep 30, 2020$464.50M+196.0%
Q2 FY2020Jun 30, 2020$426.30M+224.4%
Q1 FY2020Mar 31, 2020$160.20M+27.5%
Q4 FY2019Dec 31, 2019$176.50M+36.8%
Q3 FY2019Sep 30, 2019$156.90M+38.1%
Q2 FY2019Jun 30, 2019$131.40M+51.9%
Q1 FY2019Mar 31, 2019$125.60M+74.7%
Q4 FY2018Dec 31, 2018$129.00M+433.5%
Q3 FY2018Sep 30, 2018$113.60M+806.0%
Q2 FY2018Jun 30, 2018$86.51M+128.9%
Q1 FY2018Mar 31, 2018$71.88M+38.2%
Q4 FY2017Dec 31, 2017$24.18M-54.8%
Q3 FY2017Sep 30, 2017$12.54M-63.2%
Q2 FY2017Jun 30, 2017$37.79M–
Q1 FY2017Mar 31, 2017$52.01M–
Q4 FY2016Dec 31, 2016$53.50M–
Q3 FY2016Sep 30, 2016$34.08M–

More Tandem Diabetes Care figures

See a number that looks wrong?